EYEPOINT PHARMACEUTICALS INC's ticker is and the CUSIP is 30233G900. A total of 3 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,000 | -96.4% | 1,900 | -93.0% | 0.00% | – |
| Q1 2020 | $28,000 | -70.5% | 27,000 | -56.1% | 0.00% | -100.0% |
| Q4 2019 | $95,000 | +280.0% | 61,500 | +345.7% | 0.00% | – |
| Q3 2019 | $25,000 | – | 13,800 | +6800.0% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 200 | -99.6% | 0.00% | -100.0% |
| Q4 2018 | $92,000 | +338.1% | 48,900 | +728.8% | 0.00% | – |
| Q3 2018 | $21,000 | +200.0% | 5,900 | +63.9% | 0.00% | – |
| Q2 2018 | $7,000 | – | 3,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 27,000 | $28,000 | 0.00% |
| SIMPLEX TRADING, LLC | 33 | $3,000 | 0.00% |